Update shared on 19 Nov 2025
Fair value Increased 1.91%Analysts have raised their price target for Endurance Technologies from ₹2,947.69 to ₹3,004.07. This adjustment comes in response to slightly stronger projected revenue growth, even as a modestly higher discount rate and a marginal dip in profit margins are taken into account.
What's in the News
- A board meeting is scheduled for November 12, 2025 to consider and approve unaudited financial results for the quarter and half year ending September 30, 2025, and to discuss other matters (Key Developments).
- A special or extraordinary shareholders meeting will be held on October 14, 2025 via Postal Ballot India, with the agenda to consider the appointment of Mr. Shyamak Ramyar Tata as an independent director (Key Developments).
Valuation Changes
- Fair Value: Increased from ₹2,947.69 to ₹3,004.07. This reflects a modest upward revision in the price target.
- Discount Rate: Slightly increased from 14.43% to 14.87%.
- Revenue Growth: Projected growth edged up from 14.87% to 15.91%.
- Net Profit Margin: Marginally decreased from 8.22% to 8.01%.
- Future P/E: Declined from 41.17x to 40.19x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.